Compare Segar Kumala Indonesia Tbk (BUAH) vs Merck Tbk. (MERK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Segar Kumala Indonesia Tbk vs Merck Tbk. — how do they compare? Segar Kumala Indonesia Tbk trades at Rp520 (market cap 1.04T), while Merck Tbk. trades at Rp3,800 (market cap 1.7T). The key difference: Merck Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| BUAH | MERK | |
|---|---|---|
Market Cap | 1.04T | 1.7T |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Segar Kumala Indonesia Tbk
PT Segar Kumala Indonesia Tbk (“the Company”) was established based on Notarial Deed of P. Sutrisno A. Tampubolon, No. 14 dated June 10, 2017.
Read more on BUAH →About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →
